HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rihanna’s Fenty Was Top-Earning Celebrity Beauty Brand In 2021

Executive Summary

Pop star Rihanna’s Fenty Beauty brand accounted for more than a third of global celebrity beauty brand sales in 2021, finds sports betting site OLBG.com. Jessica Alba’s Honest Company and Kylie Jenner’s Kylie Cosmetics finished second and third, respectively.

You may also be interested in...



P&G Marketing Laces Up For Another Super Bowl Appearance, Along With Rookie E.l.f. Beauty

E.l.f. will launch its first TV spot during Super Bowl LVII, while FENTY Beauty has introduced a limited-edition makeup collection in anticipation of Rihanna headlining the halftime show. Veteran P&G will have a strong presence again this year, both during the game and in the lead-up on social media.

Ulta Beauty Achieves 38% Sales Growth In 2021, Predicts 'Normalized' 2022

Ulta’s shop-in-shop partnership with Target Corporation, expansion of its Conscious Beauty platform, and its growing investment in BIPOC-associated brands were among highlights in fiscal 2021, which benefited from comparisons against 2020 when the world locked down under siege by COVID-19.

Honest Beauty Now In More Sustainable Packaging Following IPO, Q1 Growth

The Los Angeles-based clean beauty pioneer heralded the environmentally friendly relaunch during its June discussion of fiscal 2021 first-quarter results, which included 42% growth in its Skin and Personal Care division.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152091

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel